On the whole, the loss of RKIP has a functional impact on tumour cell proliferation and is involved in tumour progression and metastasisation; in fact, the overexpression of RKIP in ccRCC cellular models inhibits EMT and reduces invasion ability [73]. The gene discussed is PEBP1; the disease is neoplasm.